ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HER2 Target Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38W15426
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global HER2 Target Drugs Market Research Report 2023
BUY CHAPTERS

Global HER2 Target Drugs Market Research Report 2025

Code: QYRE-Auto-38W15426
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
GSK
Astrazeneca plc
Seagen
MacroGenics Inc
Takeda
Novartis
RemeGen, Ltd.
Sunshine Guojian
Hengrui Medicine
Pfizer Inc
Boehringer Digelheim
Daiichi Sankyo

HER2 Target Drugs Market

The global market for HER2 Target Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
North American market for HER2 Target Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HER2 Target Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of HER2 Target Drugs include Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda, Daiichi Sankyo, Novartis AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HER2 Target Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Target Drugs.
The HER2 Target Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 Target Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Target Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HER2 Target Drugs Market Report

Report Metric Details
Report Name HER2 Target Drugs Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda, Daiichi Sankyo, Novartis AG, RemeGen, Sunshine Guojian, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HER2 Target Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HER2 Target Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the HER2 Target Drugs Market report?

Ans: The main players in the HER2 Target Drugs Market are Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, Seagen, MacroGenics, Takeda, Daiichi Sankyo, Novartis AG, RemeGen, Sunshine Guojian, Hengrui Medicine

What are the Application segmentation covered in the HER2 Target Drugs Market report?

Ans: The Applications covered in the HER2 Target Drugs Market report are Breast Cancer, Colorectal Cancer, Stomach Cancer, Other

What are the Type segmentation covered in the HER2 Target Drugs Market report?

Ans: The Types covered in the HER2 Target Drugs Market report are Monoclonal Antibodies, Small Molecule Chemicals, Antibody Drug Conjugate

Recommended Reports

Breast Cancer Therapies

Targeted Oncology Drugs

Women's Health Drugs

1 HER2 Target Drugs Market Overview
1.1 Product Definition
1.2 HER2 Target Drugs by Type
1.2.1 Global HER2 Target Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Chemicals
1.2.4 Antibody Drug Conjugate
1.3 HER2 Target Drugs by Application
1.3.1 Global HER2 Target Drugs Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.3.5 Other
1.4 Global HER2 Target Drugs Market Size Estimates and Forecasts
1.4.1 Global HER2 Target Drugs Revenue 2020-2031
1.4.2 Global HER2 Target Drugs Sales 2020-2031
1.4.3 Global HER2 Target Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HER2 Target Drugs Market Competition by Manufacturers
2.1 Global HER2 Target Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global HER2 Target Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HER2 Target Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HER2 Target Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HER2 Target Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HER2 Target Drugs, Product Type & Application
2.7 Global Key Manufacturers of HER2 Target Drugs, Date of Enter into This Industry
2.8 Global HER2 Target Drugs Market Competitive Situation and Trends
2.8.1 Global HER2 Target Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HER2 Target Drugs Players Market Share by Revenue
2.8.3 Global HER2 Target Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 Target Drugs Market Scenario by Region
3.1 Global HER2 Target Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HER2 Target Drugs Sales by Region: 2020-2031
3.2.1 Global HER2 Target Drugs Sales by Region: 2020-2025
3.2.2 Global HER2 Target Drugs Sales by Region: 2026-2031
3.3 Global HER2 Target Drugs Revenue by Region: 2020-2031
3.3.1 Global HER2 Target Drugs Revenue by Region: 2020-2025
3.3.2 Global HER2 Target Drugs Revenue by Region: 2026-2031
3.4 North America HER2 Target Drugs Market Facts & Figures by Country
3.4.1 North America HER2 Target Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HER2 Target Drugs Sales by Country (2020-2031)
3.4.3 North America HER2 Target Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 Target Drugs Market Facts & Figures by Country
3.5.1 Europe HER2 Target Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HER2 Target Drugs Sales by Country (2020-2031)
3.5.3 Europe HER2 Target Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 Target Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 Target Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HER2 Target Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific HER2 Target Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 Target Drugs Market Facts & Figures by Country
3.7.1 Latin America HER2 Target Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HER2 Target Drugs Sales by Country (2020-2031)
3.7.3 Latin America HER2 Target Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HER2 Target Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 Target Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HER2 Target Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa HER2 Target Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 Target Drugs Sales by Type (2020-2031)
4.1.1 Global HER2 Target Drugs Sales by Type (2020-2025)
4.1.2 Global HER2 Target Drugs Sales by Type (2026-2031)
4.1.3 Global HER2 Target Drugs Sales Market Share by Type (2020-2031)
4.2 Global HER2 Target Drugs Revenue by Type (2020-2031)
4.2.1 Global HER2 Target Drugs Revenue by Type (2020-2025)
4.2.2 Global HER2 Target Drugs Revenue by Type (2026-2031)
4.2.3 Global HER2 Target Drugs Revenue Market Share by Type (2020-2031)
4.3 Global HER2 Target Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global HER2 Target Drugs Sales by Application (2020-2031)
5.1.1 Global HER2 Target Drugs Sales by Application (2020-2025)
5.1.2 Global HER2 Target Drugs Sales by Application (2026-2031)
5.1.3 Global HER2 Target Drugs Sales Market Share by Application (2020-2031)
5.2 Global HER2 Target Drugs Revenue by Application (2020-2031)
5.2.1 Global HER2 Target Drugs Revenue by Application (2020-2025)
5.2.2 Global HER2 Target Drugs Revenue by Application (2026-2031)
5.2.3 Global HER2 Target Drugs Revenue Market Share by Application (2020-2031)
5.3 Global HER2 Target Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche HER2 Target Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK HER2 Target Drugs Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Boehringer Digelheim
6.3.1 Boehringer Digelheim Company Information
6.3.2 Boehringer Digelheim Description and Business Overview
6.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Digelheim HER2 Target Drugs Product Portfolio
6.3.5 Boehringer Digelheim Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer HER2 Target Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca HER2 Target Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Seagen
6.6.1 Seagen Company Information
6.6.2 Seagen Description and Business Overview
6.6.3 Seagen HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Seagen HER2 Target Drugs Product Portfolio
6.6.5 Seagen Recent Developments/Updates
6.7 MacroGenics
6.7.1 MacroGenics Company Information
6.7.2 MacroGenics Description and Business Overview
6.7.3 MacroGenics HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MacroGenics HER2 Target Drugs Product Portfolio
6.7.5 MacroGenics Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Company Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda HER2 Target Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Daiichi Sankyo
6.9.1 Daiichi Sankyo Company Information
6.9.2 Daiichi Sankyo Description and Business Overview
6.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Daiichi Sankyo HER2 Target Drugs Product Portfolio
6.9.5 Daiichi Sankyo Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Company Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis AG HER2 Target Drugs Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 RemeGen
6.11.1 RemeGen Company Information
6.11.2 RemeGen Description and Business Overview
6.11.3 RemeGen HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 RemeGen HER2 Target Drugs Product Portfolio
6.11.5 RemeGen Recent Developments/Updates
6.12 Sunshine Guojian
6.12.1 Sunshine Guojian Company Information
6.12.2 Sunshine Guojian Description and Business Overview
6.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sunshine Guojian HER2 Target Drugs Product Portfolio
6.12.5 Sunshine Guojian Recent Developments/Updates
6.13 Hengrui Medicine
6.13.1 Hengrui Medicine Company Information
6.13.2 Hengrui Medicine Description and Business Overview
6.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hengrui Medicine HER2 Target Drugs Product Portfolio
6.13.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 Target Drugs Industry Chain Analysis
7.2 HER2 Target Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 Target Drugs Production Mode & Process Analysis
7.4 HER2 Target Drugs Sales and Marketing
7.4.1 HER2 Target Drugs Sales Channels
7.4.2 HER2 Target Drugs Distributors
7.5 HER2 Target Drugs Customer Analysis
8 HER2 Target Drugs Market Dynamics
8.1 HER2 Target Drugs Industry Trends
8.2 HER2 Target Drugs Market Drivers
8.3 HER2 Target Drugs Market Challenges
8.4 HER2 Target Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
GSK
Astrazeneca plc
Seagen
MacroGenics Inc
Takeda
Novartis
RemeGen, Ltd.
Sunshine Guojian
Hengrui Medicine
Pfizer Inc
Boehringer Digelheim
Daiichi Sankyo
List of Tables
 Table 1. Global HER2 Target Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global HER2 Target Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global HER2 Target Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global HER2 Target Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global HER2 Target Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global HER2 Target Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global HER2 Target Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market HER2 Target Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of HER2 Target Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HER2 Target Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HER2 Target Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of HER2 Target Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HER2 Target Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Target Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HER2 Target Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global HER2 Target Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global HER2 Target Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global HER2 Target Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global HER2 Target Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global HER2 Target Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global HER2 Target Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global HER2 Target Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global HER2 Target Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America HER2 Target Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America HER2 Target Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America HER2 Target Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America HER2 Target Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America HER2 Target Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe HER2 Target Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe HER2 Target Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe HER2 Target Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe HER2 Target Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe HER2 Target Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific HER2 Target Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific HER2 Target Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific HER2 Target Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific HER2 Target Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific HER2 Target Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America HER2 Target Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America HER2 Target Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America HER2 Target Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America HER2 Target Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America HER2 Target Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa HER2 Target Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa HER2 Target Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa HER2 Target Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa HER2 Target Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa HER2 Target Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global HER2 Target Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global HER2 Target Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global HER2 Target Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global HER2 Target Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global HER2 Target Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global HER2 Target Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global HER2 Target Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global HER2 Target Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global HER2 Target Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global HER2 Target Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global HER2 Target Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global HER2 Target Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global HER2 Target Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global HER2 Target Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global HER2 Target Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global HER2 Target Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global HER2 Target Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global HER2 Target Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global HER2 Target Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global HER2 Target Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche HER2 Target Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK HER2 Target Drugs Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Boehringer Digelheim Company Information
 Table 81. Boehringer Digelheim Description and Business Overview
 Table 82. Boehringer Digelheim HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Digelheim HER2 Target Drugs Product
 Table 84. Boehringer Digelheim Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer HER2 Target Drugs Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca HER2 Target Drugs Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Seagen Company Information
 Table 96. Seagen Description and Business Overview
 Table 97. Seagen HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Seagen HER2 Target Drugs Product
 Table 99. Seagen Recent Developments/Updates
 Table 100. MacroGenics Company Information
 Table 101. MacroGenics Description and Business Overview
 Table 102. MacroGenics HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MacroGenics HER2 Target Drugs Product
 Table 104. MacroGenics Recent Developments/Updates
 Table 105. Takeda Company Information
 Table 106. Takeda Description and Business Overview
 Table 107. Takeda HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Takeda HER2 Target Drugs Product
 Table 109. Takeda Recent Developments/Updates
 Table 110. Daiichi Sankyo Company Information
 Table 111. Daiichi Sankyo Description and Business Overview
 Table 112. Daiichi Sankyo HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Daiichi Sankyo HER2 Target Drugs Product
 Table 114. Daiichi Sankyo Recent Developments/Updates
 Table 115. Novartis AG Company Information
 Table 116. Novartis AG Description and Business Overview
 Table 117. Novartis AG HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis AG HER2 Target Drugs Product
 Table 119. Novartis AG Recent Developments/Updates
 Table 120. RemeGen Company Information
 Table 121. RemeGen Description and Business Overview
 Table 122. RemeGen HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. RemeGen HER2 Target Drugs Product
 Table 124. RemeGen Recent Developments/Updates
 Table 125. Sunshine Guojian Company Information
 Table 126. Sunshine Guojian Description and Business Overview
 Table 127. Sunshine Guojian HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sunshine Guojian HER2 Target Drugs Product
 Table 129. Sunshine Guojian Recent Developments/Updates
 Table 130. Hengrui Medicine Company Information
 Table 131. Hengrui Medicine Description and Business Overview
 Table 132. Hengrui Medicine HER2 Target Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hengrui Medicine HER2 Target Drugs Product
 Table 134. Hengrui Medicine Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. HER2 Target Drugs Distributors List
 Table 138. HER2 Target Drugs Customers List
 Table 139. HER2 Target Drugs Market Trends
 Table 140. HER2 Target Drugs Market Drivers
 Table 141. HER2 Target Drugs Market Challenges
 Table 142. HER2 Target Drugs Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HER2 Target Drugs
 Figure 2. Global HER2 Target Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HER2 Target Drugs Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Small Molecule Chemicals Product Picture
 Figure 6. Antibody Drug Conjugate Product Picture
 Figure 7. Global HER2 Target Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global HER2 Target Drugs Market Share by Application: 2024 & 2031
 Figure 9. Breast Cancer
 Figure 10. Colorectal Cancer
 Figure 11. Stomach Cancer
 Figure 12. Other
 Figure 13. Global HER2 Target Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global HER2 Target Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global HER2 Target Drugs Sales (2020-2031) & (K Units)
 Figure 16. Global HER2 Target Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 17. HER2 Target Drugs Report Years Considered
 Figure 18. HER2 Target Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global HER2 Target Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest HER2 Target Drugs Players: Market Share by Revenue in HER2 Target Drugs in 2024
 Figure 21. HER2 Target Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global HER2 Target Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America HER2 Target Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America HER2 Target Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. United States HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe HER2 Target Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe HER2 Target Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific HER2 Target Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific HER2 Target Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America HER2 Target Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America HER2 Target Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa HER2 Target Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa HER2 Target Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE HER2 Target Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of HER2 Target Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of HER2 Target Drugs by Type (2020-2031)
 Figure 55. Global HER2 Target Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of HER2 Target Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of HER2 Target Drugs by Application (2020-2031)
 Figure 58. Global HER2 Target Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 59. HER2 Target Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2030
Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024
Global HER2 Positive Breast Cancer Market Research Report 2024
Global Anti HER2 Therapy Market Research Report 2025
Global Epidermal Growth Factor Receptor Inhibitors Market Research Report 2024
Global Human EGFR Gene Mutation Detection Kit Market Research Report 2024
Global HER2 Antibody Market Research Report 2025
Global HER2 Targeted Therapy Market Research Report 2024
Global EGFR TKI Market Research Report 2024
Global HR HER2 Breast Cancer Market Research Report 2024
Global HER 2 Targeted Drugs for Breast Cancer Market Research Report 2024
Drugs for HR HER2 Advanced Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Receptor Tyrosine protein Kinase ERBB 3 Antibody Market Research Report 2024
Global Targeted Drug HER2 Inhibitors for NSCLC Market Research Report 2024
Global HER2 Antibody Drug Conjugate Market Research Report 2025
Global TYK2 Targeting Drugs Market Research Report 2024
Global MET Inhibitor Drugs Market Research Report 2025
Fibroblast Growth Factor Receptor 2 Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mitogen Activated Protein Kinase Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions